Scientists from Durin Technologies, Inc., and the University ofMedicine and Dentistry of New Jersey (UMDNJ)-School of OsteopathicMedicine have developed a blood test that uses human proteinmicroarrays to detect the presence of specific antibodies in theblood that can be used to diagnose Alzheimer's disease with unprecedented accuracy. The test has a diagnostic sensitivityof 96 percent and a specificity of 92.5 percent and has thepotential to spot Alzheimer's in its earliest stages, years beforesymptoms such as memory loss, poor judgment or erratic behaviorappear. The same test also demonstrated the ability to distinguishAlzheimer's from Parkinson's disease , a closely related neurodegenerative disorder. The research team'sfindings appear online in PLoS ONE. More than 100 years after it was first described, Alzheimer'saffects nearly 36 million people worldwide, yet there remains onlyone definitive way to diagnose the disease the direct examinationof brain tissue following the patient's death. "There's a dire need for an accurate, relatively non-invasive andinexpensive diagnostic test for Alzheimer's," said Robert Nagele,PhD, founder of Durin Technologies, Inc., and a professor at theUMDNJ-School of Osteopathic Medicine. "A test that can not onlydiagnose the disease in individuals showing telltale symptoms, butpossibly also detect the disease years before these symptoms appearwould make early therapeutic intervention possible. This would be asignificant breakthrough as pharmaceutical companies are nowworking feverishly to develop new drugs that can stop or slow theprogression of Alzheimer's." An investment in Durin Technologies, Inc., by Foundation VentureCapital Group (FVCG), LLC, a New Jersey Health Foundation affiliatethat invests in start-up companies founded by researchers at UMDNJ,provided necessary funding to move Nagele's research forward. Nagele says this discovery may have a profound clinical impact andcould ultimately be well-suited for inclusion in routine healthcare, especially if it can also be applied to detection of otherdiseases. "Because this method requires only a small blood sample,it avoids the expense and patient discomfort of other proposedAlzheimer's diagnostic tests such as those involving neuroimagingtechniques, more invasive procedures and hospitalization. Discoveryof other disease-specific autoantibody signatures could alsoconceivably lead to the development of successful and relativelyinexpensive diagnostics for a wide variety of diseases," he said. An early diagnostic test could also serve to rule out Alzheimer'sdisease for some patients who are experiencing mild or intermittentmemory loss. In about 20 percent of these cases, the patient'smemory problems result from another condition such as anxiety , depression or a reaction to medication. Source: University of Medicine and Dentistry of New Jersey (UMDNJ) Additional References Citations. I am an expert from slimming-beautymachine.com, while we provides the quality product, such as China E Light IPL Hair Removal , IPL Spare Parts Manufacturer, Slimming Beauty Machine,and more.
Related Articles -
China E Light IPL Hair Removal, IPL Spare Parts Manufacturer,
|